Geographical distribution, evaluation of risk of dengue and its relationship with the El Niño Southern Oscillation in an endemic region of Peru between 2004 and 2015

Objective

To determine the geographical distribution and risk stratification of dengue infection in an endemic region of Peru, and its relationship with the presence of El Niño Southern Oscillation (ENSO).

Results

For the analysis, the definition and information about the ENSO events in Peru was obtained from the SENAMHI and IGP reports. The geographical distribution of dengue cases in the territory comprising the 11 districts is homogeneous. There were 1 498 confirmed cases of dengue reported, the highest incidence was determined in Puerto Inca where it reached an incidence of 3210.14/100,000 hab. Of the 11 districts, 2 were classified as a high risk of transmission, 3 as moderate risk, 3 as low risk and in 3 of them the risk of virus transmission could not be determined.

Electronic supplementary material

The online version of this article (10.1186/s13104-019-4537-0) contains supplementary material, which is available to authorized users.

First outbreak of Oropouche Fever reported in a non-endemic western region of the Peruvian Amazon: Molecular diagnosis and clinical characteristics

INTRODUCTION

Oropouche fever is an under-reported and emerging infectious disease caused by Oropouche virus (OROV). Its incidence is under-estimated mainly due to clinical similarities with other endemic arboviral diseases and the lack of specific diagnostic tests. We report the first outbreak of Oropouche fever in a western region of the Peruvian Amazon in Huanuco, Peru.

METHODS

A transversal study was carried out during an outbreak in the western Region of Huanuco, Peru between January and July of 2016. Blood samples of 268 patients with acute febrile syndrome were collected and analyzed for OROV via RT- PCR and genetic sequencing.

RESULTS

Of all 268 patients, 46 (17%) cases tested positive for OROV. The most common symptoms reported were headache with a frequency of 87% (n = 40) followed by myalgia with 76% (n = 35), arthralgia with 65.2% (n = 30), retro-ocular pain 60.8% (n = 28) and hyporexia with 50% (n = 23). Some patients showed a clinical presentation suggestive of severe OROV infection, of which 4.3% (n = 2) had low platelet count, 8.6% (n = 4) had intense abdominal pain, and 2.1% (n = 1) had a presentation with thoracic pain.

CONCLUSION

This study reports an outbreak of OROV in a region where this virus was not previously identified. The disease caused by OROV is an emerging, underdiagnosed infection that requires further research to determine its virulence, pathogenesis, host range and vectors involved in the urban and sylvatic cycles as well as identifying new genotypes to implement sensitive and specific diagnostic tools that can be applied to endemic regions.